Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms RC-0h |
Target |
Action degraders |
Mechanism BTK degraders(Tyrosine-protein kinase BTK degraders) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC52H53N13O11 |
InChIKeyWTOVIXLJDYFDNO-TWTNBJNSSA-N |
CAS Registry- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chronic Lymphocytic Leukemia | Preclinical | Israel | 05 May 2020 |





